Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Toward 3D dose verification of an electronic brachytherapy source with a plastic scintillation detector

P. Georgi, G. Kertzscher, L. Nyvang, J. Šolc, T. Schneider, K. Tanderup, JG. Johansen

. 2022 ; 49 (5) : 3432-3443. [pub] 20220303

Language English Country United States

Document type Journal Article

Grant support
18NRM02 PRISM-eBT EMPIR from Participating States and from the European Union's Horizon 2020 research and innovation Programme
NNF19OC0058756 Novo Nordisk Fonden

BACKGROUND: Electronic brachytherapy (eBT) is considered a safe treatment with good outcomes. However, eBT lacks standardized and independent dose verification, which could impede future use. PURPOSE: To validate the 3D dose-to-water distribution of an electronic brachytherapy (eBT) source using a small-volume plastic scintillation detector (PSD). METHODS: The relative dose distribution of a Papillon 50 (P50) (Ariane Medical Systems, UK) eBT source was measured in water with a PSD consisting of a cylindrical scintillating BCF-12 fiber (length: 0.5 mm, Ø: 1 mm) coupled to a photodetector via an optical fiber. The measurements were performed with the PSD mounted on a motorized stage in a water phantom (MP3) (PTW, Germany). This allowed the sensitive volume of the PSD to be moved to predetermined positions relative to the P50 applicator, which pointed vertically downward while just breaching the water surface. The percentage depth-dose (PDD) was measured from 0 to 50 mm source-to-detector distance (SDD) in 1-3 mm steps. Dose profiles were measured along two perpendicular axes at five different SDDs with step sizes down to 0.5 mm. Characterization of the PSD consisted of determining the energy correction through Monte Carlo (MC) simulation and by measuring the stability and dose rate linearity using a well-type ionization chamber as a reference. The measured PDD and profiles were validated with corresponding MC simulations. RESULTS: The measured and simulated PDD curves agreed within 2% (except at 0 mm and 43 mm depth) after the PSD measurements were corrected for energy dependency. The absorbed dose decreased by a factor of 2 at 7 mm depth and by a factor of 10 at 26 mm depth. The measured dose profiles showed dose gradients at the profile edges of more than 50%/mm at 5 mm depth and 15%/mm at 50 mm depth. The measured profile widths increased 0.66 mm per 1 mm depth, while the simulated profile widths increased 0.74 mm per 1 mm depth. An azimuthal dependency of > 10% was observed in the dose at 10 mm distance from the beam center. The total uncertainty of the measured relative dose is < 2.5% with a positional uncertainty of 0.4 mm. The measurements for a full 3D dose characterization (PDD and profiles) can be carried out within 8 h, the limiting factor being cooling of the P50. CONCLUSION: The PSD and MP3 water phantoms provided a method to independently verify the relative 3D dose distribution in water of an eBT source.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22018626
003      
CZ-PrNML
005      
20220804134921.0
007      
ta
008      
220720s2022 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/mp.15568 $2 doi
035    __
$a (PubMed)35196404
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Georgi, Peter $u Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
245    10
$a Toward 3D dose verification of an electronic brachytherapy source with a plastic scintillation detector / $c P. Georgi, G. Kertzscher, L. Nyvang, J. Šolc, T. Schneider, K. Tanderup, JG. Johansen
520    9_
$a BACKGROUND: Electronic brachytherapy (eBT) is considered a safe treatment with good outcomes. However, eBT lacks standardized and independent dose verification, which could impede future use. PURPOSE: To validate the 3D dose-to-water distribution of an electronic brachytherapy (eBT) source using a small-volume plastic scintillation detector (PSD). METHODS: The relative dose distribution of a Papillon 50 (P50) (Ariane Medical Systems, UK) eBT source was measured in water with a PSD consisting of a cylindrical scintillating BCF-12 fiber (length: 0.5 mm, Ø: 1 mm) coupled to a photodetector via an optical fiber. The measurements were performed with the PSD mounted on a motorized stage in a water phantom (MP3) (PTW, Germany). This allowed the sensitive volume of the PSD to be moved to predetermined positions relative to the P50 applicator, which pointed vertically downward while just breaching the water surface. The percentage depth-dose (PDD) was measured from 0 to 50 mm source-to-detector distance (SDD) in 1-3 mm steps. Dose profiles were measured along two perpendicular axes at five different SDDs with step sizes down to 0.5 mm. Characterization of the PSD consisted of determining the energy correction through Monte Carlo (MC) simulation and by measuring the stability and dose rate linearity using a well-type ionization chamber as a reference. The measured PDD and profiles were validated with corresponding MC simulations. RESULTS: The measured and simulated PDD curves agreed within 2% (except at 0 mm and 43 mm depth) after the PSD measurements were corrected for energy dependency. The absorbed dose decreased by a factor of 2 at 7 mm depth and by a factor of 10 at 26 mm depth. The measured dose profiles showed dose gradients at the profile edges of more than 50%/mm at 5 mm depth and 15%/mm at 50 mm depth. The measured profile widths increased 0.66 mm per 1 mm depth, while the simulated profile widths increased 0.74 mm per 1 mm depth. An azimuthal dependency of > 10% was observed in the dose at 10 mm distance from the beam center. The total uncertainty of the measured relative dose is < 2.5% with a positional uncertainty of 0.4 mm. The measurements for a full 3D dose characterization (PDD and profiles) can be carried out within 8 h, the limiting factor being cooling of the P50. CONCLUSION: The PSD and MP3 water phantoms provided a method to independently verify the relative 3D dose distribution in water of an eBT source.
650    12
$a brachyterapie $7 D001918
650    _2
$a elektronika $7 D004581
650    _2
$a metoda Monte Carlo $7 D009010
650    _2
$a plastické hmoty $7 D010969
650    _2
$a radiometrie $7 D011874
650    _2
$a voda $7 D014867
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kertzscher, Gustavo $u Department of Oncology, Aarhus University Hospital, Aarhus N, Denmark
700    1_
$a Nyvang, Lars $u Department of Oncology, Aarhus University Hospital, Aarhus N, Denmark
700    1_
$a Šolc, Jaroslav $u Photon Dosimetry Laboratory, Czech Metrology Institute, Prague, Czech Republic
700    1_
$a Schneider, Thorsten $u Division for Ionizing Radiation, WG 6.34 "Dosimetry for Brachytherapy and Beta Radiation Protection", Physicalisch-Technische Bundesanstalt (PTB), Braunschweig, Germany
700    1_
$a Tanderup, Kari $u Department of Clinical Medicine, Aarhus University, Aarhus, Denmark $u Department of Oncology, Aarhus University Hospital, Aarhus N, Denmark
700    1_
$a Johansen, Jacob Graversen $u Department of Clinical Medicine, Aarhus University, Aarhus, Denmark $u Department of Oncology, Aarhus University Hospital, Aarhus N, Denmark
773    0_
$w MED00003245 $t Medical physics $x 2473-4209 $g Roč. 49, č. 5 (2022), s. 3432-3443
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35196404 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804134915 $b ABA008
999    __
$a ok $b bmc $g 1822305 $s 1169869
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 49 $c 5 $d 3432-3443 $e 20220303 $i 2473-4209 $m Medical physics $n Med Phys $x MED00003245
GRA    __
$a 18NRM02 PRISM-eBT $p EMPIR from Participating States and from the European Union's Horizon 2020 research and innovation Programme
GRA    __
$a NNF19OC0058756 $p Novo Nordisk Fonden
LZP    __
$a Pubmed-20220720

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...